Highly motivated, result oriented diligent team leader and team player. Successfully lead translational research / pre-clinical pharmacology/toxicological studies in industry as well as basic research in academia. Immunologist with expertise in the design as well as deadline-centric execution of research projects aimed at therapeutic endpoints in the treatment of cancer and autoimmune-inflammatory disorders using small molecules, mAb and fusion proteins. Highly proficient in development of cell based and molecular biology assays for biomarker development and pre-clinical studies under GLP and GMP environment. Extensive hands on experience in designing, implementing and executing in vitro and in vivo studies. Excellent experience with flow cytometry, ELISA, OMIC based assays and real time PCR based assays. More than 7 years of experience in protein production includes molecular engineering and purification of enzymes, mAb and fusion proteins. Ten years of proven record of managing in excess of 16 personnel, budgets exceeding $5 million and cross-functional team building. Innovation supported by submission of nine patents in the last 5 years and peer reviewed publications. MANAGEMENT Excellent know-how of various aspects of translational medicine to facilitates the bench to bedside transition. • Skillful in compiling Gantt chart, filing patents, and pre-IND/ IND applications for development of clinical products. • Supervised Ph.D. Senior Research Scientists and Research Associates• Proficiencies in identifying and auditing contract research organizations (CRO) • Recognized as an effective problem-solver with strong conflict resolution, effective communicator to various levels, strong project management and negotiation skills.• Effectively collaborated with angel as well as private investor to define new technologies.• Cost saving initiatives while developing projects plans.Specialties: Project planning Collaborating with corporate partners and auditing CROs.Protecting IP in vitro and in vivo pharmacology studies to support IND-enabling characterization of biopharmaceuticals. Expression and purification of proteins in E.coli and mammalian cellsAssay development - Flow cytometry, ELISA, ELISPOT, OMIC and real time PCR.Immunotoxicological studiesImmunology, Biochemistry, Molecular BiologyCancer, autoimmunity, inflammation and HIV immunopathogenesis.